| Cyclosporine | Approved Investigational Vet Approved | ENPP3 | 5169 |
downregulated | Cyclosporine results in decreased expression of ENPP3 mRNA | 6q23.2 | |
| Cyclosporine | Approved Investigational Vet Approved | ENPP4 | 22875 |
downregulated | Cyclosporine results in decreased expression of ENPP4 mRNA | 6p21.1 | |
| Cyclosporine | Approved Investigational Vet Approved | ENPP6 | 133121 |
downregulated | Cyclosporine results in decreased expression of ENPP6 mRNA | 4q35.1 | |
| Cyclosporine | Approved Investigational Vet Approved | ENTPD4 | 9583 |
upregulated | Cyclosporine results in increased expression of ENTPD4 mRNA | 8p21.3 | |
| Cyclosporine | Approved Investigational Vet Approved | ENTPD5 | 957 |
downregulated | Cyclosporine results in decreased expression of ENTPD5 mRNA | 14q24.3 | |
| Cyclosporine | Approved Investigational Vet Approved | ENTPD7 | 57089 |
upregulated | Cyclosporine results in increased expression of ENTPD7 mRNA | 10q24.2 | |
| Cyclosporine | Approved Investigational Vet Approved | ENY2 | 56943 |
downregulated | Cyclosporine results in decreased expression of ENY2 mRNA | 8q23.1 | |
| Cyclosporine | Approved Investigational Vet Approved | EPAS1 | 2034 |
downregulated | Cyclosporine results in decreased expression of EPAS1 mRNA | 2p21 | |
| Cyclosporine | Approved Investigational Vet Approved | EPAS1 | 2034 |
upregulated | Cyclosporine results in increased expression of EPAS1 mRNA | 2p21 | |
| Cyclosporine | Approved Investigational Vet Approved | EPB41 | 2035 |
upregulated | Cyclosporine results in increased expression of EPB41 mRNA | 1p35.3 | |
| Cyclosporine | Approved Investigational Vet Approved | EPB41L2 | 2037 |
downregulated | Cyclosporine results in decreased expression of EPB41L2 mRNA | 6q23.1-q23.2 | |
| Cyclosporine | Approved Investigational Vet Approved | EPB41L4A-AS1 | 114915 |
upregulated | Cyclosporine results in increased expression of EPB41L4A-AS1 mRNA | 5q22.1 | |
| Cyclosporine | Approved Investigational Vet Approved | EPC2 | 26122 |
upregulated | Cyclosporine results in increased expression of EPC2 mRNA | 2q23.1 | |
| Cyclosporine | Approved Investigational Vet Approved | EPHA1 | 2041 |
downregulated | Cyclosporine results in decreased expression of EPHA1 mRNA | 7q34-q35 | |
| Cyclosporine | Approved Investigational Vet Approved | EPHA2 | 1969 |
upregulated | Cyclosporine results in increased expression of EPHA2 mRNA | 1p36.13 | |
| Cyclosporine | Approved Investigational Vet Approved | EPHA4 | 2043 |
downregulated | Cyclosporine results in decreased expression of EPHA4 mRNA | 2q36.1 | |
| Cyclosporine | Approved Investigational Vet Approved | EPHA5 | 2044 |
downregulated | Cyclosporine results in decreased expression of EPHA5 mRNA | 4q13.1-q13.2 | |
| Cyclosporine | Approved Investigational Vet Approved | EPHB4 | 2050 |
downregulated | Cyclosporine results in decreased expression of EPHB4 mRNA | 7q22.1 | |
| Cyclosporine | Approved Investigational Vet Approved | EPHB6 | 2051 |
downregulated | Cyclosporine results in decreased expression of EPHB6 mRNA | 7q34 | |
| Cyclosporine | Approved Investigational Vet Approved | EPHX1 | 2052 |
downregulated | Cyclosporine results in decreased expression of EPHX1 mRNA | 1q42.12 | |
| Cyclosporine | Approved Investigational Vet Approved | EPHX2 | 2053 |
downregulated | Cyclosporine results in decreased expression of EPHX2 mRNA | 8p21.2-p21.1 | |
| Cyclosporine | Approved Investigational Vet Approved | EPM2A | 7957 |
downregulated | Cyclosporine results in decreased expression of EPM2A mRNA | 6q24.3 | |
| Cyclosporine | Approved Investigational Vet Approved | EPM2AIP1 | 9852 |
downregulated | Cyclosporine results in decreased expression of EPM2AIP1 mRNA | 3p22.2 | |
| Cyclosporine | Approved Investigational Vet Approved | EPO | 2056 |
downregulated | Cyclosporine results in decreased expression of EPO mRNA | 7q22.1 | |
| Cyclosporine | Approved Investigational Vet Approved | EPOP | 100170841 |
downregulated | Cyclosporine results in decreased expression of EPOP mRNA | 17q12 | |